The Dexcom 15-day G7 continuous glucose monitor (CGM) is accurate and safe for use up to 15.5 days in adults with diabetes. Currently under review by the US Food and Drug Administration, it is more ...
Late Monday, the agency overseeing Medicare and Medicaid proposed $4.5 billion of spending cuts for home healthcare, and new economies on diabetes devices. The spending cuts are another problem for ...
Dexcom, the local maker of continuous glucose monitors, received a warning letter from the Food and Drug Administration last week citing issues at two of its manufacturing facilities. The warning ...
Shares of medical device makers DexcomDXCM, Tandem DiabetesTNDM and InsuletPODD skidded Tuesday on a proposal that would cut Medicare reimbursements for wearable diabetes tech. Late Monday, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback